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Purpose: To describe the technique of deep sclerectomy 
with the new Esnoper-Clip® implant, the clinical outcome and 
the anatomic characteristics of filtering blebs, using anterior 
segment optical coherence tomography (AS-OCT).
Methods: A prospective case-series study was conducted in 
five eyes (5 patients) with open angle glaucoma. The fornix-
based deep sclerectomy with Esnoper-Clip® implant was done 
by the same surgeon. In one case, mitomycin C was used during 
surgery. All participants underwent a complete ophthalmic 
examination and AS-OCT (Visante®) preoperatively, then at 
each follow-up visit, at 1 day, 1 week, 1 month, 6 months and 
1 year postoperatively. Scans were obtained through sagittal 
and transversal plans to the implant.
Results: Intraocular pressure (IOP) was significantly reduced 
(p < 0.05) from a mean preoperative value of 23.4 ± 8.6 mm 
Hg (n = 3.8 glaucoma medications) to a postoperative value of 
6.0 ± 2.5 (n = 0), 10.6 ± 5.4 (n = 0), 13 ± 1.6 (n = 0.4), 12.4 ± 2.1 
(n = 0.2) and 14.4 ± 1.5 (n = 0.2) at 1 day, 1 week, 1 month, 
6 months and 1 year respectively. AS-OCT allowed the visuali-
zation of the two plates of the implant (scleral and supra sciliary), 
the trabeculodescemetic membrane and the hyporeflective 
spaces in the bleb wall thickness and in supra scleral and 
suprachoroidal localizations. An immediate postoperative 
hypotony and an anteriorization of the implant associated 
to trabeculodescemetic membrane rupture, were detected, 
although without significant clinical repercussions.
Conclusion: Our first five deep sclerectomy with Esnoper-Clip 
implantation analysis suggest an effective and well-tolerated 
method to reduce IOP. AS-OCT is a noninvasive imaging tech-
nique that allows the anatomic analysis of the drainage mecha-
nisms after glaucoma surgery. 
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INTRODuCTION
In the last years, deep sclerectomy (DS) has gained 
impor tance in glaucoma surgical treatment. In contrast 
to trabeculectomy, it enhances aqueous humor outflow 
acting on the major resistance site without entering the 
anterior chamber, thus reducing the incidence of intra and 
postoperative overfiltration, hypotony and its potential 
sequelae.1-8 Moreover, the incidence of cataract,8-10 
hyphema,5 endothelial damage11 and macular edema 
is lower5 with DS. Although it is widely accepted that 
the DS is safer, remains some controversy about the 
intraocular pressure (IOP)-lowering effects. Chiselita 
et al12 and Cheng et al1 described lower efficacy than 
trabeculectomy, in contrast to El Sayyad et al13 that 
described similar efficacy. Mitomycin-C and many types 
of implants (Aquaflow,® SK-Gel,® T-flux,® Esnoper®)2 have 
been used to improve the efficacy of this technique, with 
reported similar results to trabeculectomy,4,5,14 although 
it is not consensual.6,8 Esnoper-Clip® is a nonreabsorbable 
implant, which objective is to maximize all aqueous 
humor drainage pathways. 
Anterior segment optical coherence tomography (AS-
OCT) is a noninvasive, noncontact imaging technology 
that provides high-resolution cross-sectional images of 
anterior segment.15 It has been used to evaluate filtering 
blebs after trabeculectomy16-19 and DS,16,17,20-23 allowing 
a better understanding about aqueous humor drainage 
pathways and its function.
The purpose of this study was to describe the 
techni que of deep sclerectomy with the new Esnoper-
Clip® implant, the clinical outcome (IOP decrease and 
complications with one year follow-up) and the anatomic 
characteristics of filtering blebs, using AS-OCT. To our 




A prospective case-series study was conducted in five 
eyes of five patients (4♂: 1♀), with a mean age of 61 ± 15.6 
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years, followed in Glaucoma Section of Ophthalmology 
Department of Central Lisbon Hospital Center (Table 1). 
Three patients had primary open-angle glaucoma 
(POAG) and two pseudoexfoliative glaucoma (PEXG), 
with characteristic structural and functional findings. 
Two of them had previous cataract surgery for more 
than 6 months. All patients had uncontrolled glaucoma 
despite being on maximal medical therapy. 
PROCEDuRES
Esnoper-Clip® is a nonabsorbable foldable implant 
with two plates (scleral and supraciliary), composed by 
2-hydroxyethyl methacrylate, a nonionic polymer with 
low tendency for protein deposits. Its length, unfolded, 
is 5.5 mm (3 mm scleral plate and 2.5 mm supraciliary 
plate), the base width is 2.2 mm and the thickness is 
0.2 mm (Fig. 1).
The fornix-based deep sclerectomy with Esnoper-
Clip® implant was done by the same surgeon. After 
scleral exposure, a superficial flap of a 1/3 of sclera 
thickness was created (5.0 × 5.0 mm), 1 mm beyond the 
limbus. Then, a second deeper flap was done (4.0 × 4.0 
mm), the peeling of Schlemm s´ canal was completed 
and the deepest sclera flap was excised, leaving the 
trabeculodescemetic membrane patent. Esnoper-Clip® 
implant was inserted, one plate in the intrascleral space 
and the other in the supraciliary space. At last, the scleral 
Table 1: Patients’ features





1 58 ♂ Right POAG Cataract
2 71 ♀ Left PEXG No
3 51 ♂ Left POAG No
4 43 ♂ Right PEXG No
5 82 ♂ Left POAG Cataract
Fig. 1: Esnoper-Clip® implant
flap was sutured with monofilament 10-0 as long as the 
conjunctiva. In one case, mitomycin C was used during 
surgery (ethnic and inflammatory factors).
All participants underwent a full ophthalmologic 
examination (including measurement of IOP with 
Goldmann tonometer) and AS-OCT (Visante®) preope-
ratively, then at 1 day, 1 week, 1 month, 6 months and 
1 year postoperatively. Scans were done through sagittal 
and transversal plans to the implant (Fig. 2).
The number of glaucoma medications needed to lower 
IOP, after the surgical procedure, was documented.
STATISTICAL ANALySIS
Statistical analysis was conducted using SPSS Statistics 
version 20.0. The average and standard deviation (SD) 
of IOP and number of glaucoma medications were 
calculated. These values were compared between the 
different follow-up times using Mann-Whitney test. 
p-values less than 0.05 were considered statistically 
significant.
Ethics Statement
The study was approved by the Human Research Ethics 
Committee of the Central Lisbon Hospital Center and 
followed the tenets of the Declaration of Helsinki. Written 
informed consent was obtained from all participants. 
RESuLTS
Intraocular pressure and number of glaucoma medications 
were significantly reduced (p < 0.05) from a preoperative 
value of 23.4 ± 8.6 mm Hg (n = 3.8 glaucoma medications) 
to a postoperative value of 6.0 ± 2.5 (n = 0), 10.6 ± 5.4 
(n = 0), 13 ± 1.6 (n = 0.4), 12.4 ± 2.1 (n = 0.2) and 14.4 ± 1.5 
(n = 0.2) at 1 day, 1 week, 1 month, 6 months and 1 year 
respectively (Table 2).
Fig. 2: Anterior segment optical coherence tomography scans 
were done through sagittal and transversal plans to the implant 
(as shown by lines)
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Table 2: Intraocular pressure and number of glaucoma medications (n) preoperatively and at 1 day, 1 week,  
1 month, 6 months and 1 year postoperatively
Preoperatively 1 day 1 week 1 month 6 months 1 year































Figs 3A to C: Anterior segment optical coherence tomography: 
(A) Longitudinal scan showing the double plate of Esnoper-Clip® 
implant (arrow) and an intact trabeculodescemetic membrane 
(arrow head), (B) transversal scan showing the double plate of 
the Esnoper-Clip® implant (arrow) and an hyporeflective space 
suggestive of a scleral route (arrow head) between intrascleral 
space and suprascleral space, (C) longitudinal scan showing 
hyporeflective spaces in the bleb wall thickness (arrow) and in 
suprascleral (arrow head) and suprachoroidal localizations (empty 
arrow head)
Figs 4A and B: Anteriorization of the Esnoper-Clip® implant: 
(A) Image of the implant in the anterior chamber seen by 
gonio scopy, (B) longitudinal scan of AS-OCT showing the 
double plate of Esnoper-Clip® implant (arrow) and the ruptured 
trabeculodescemetic membrane (arrow head)
Anterior segment optical coherence tomography allowed 
the visualization of the two plates of the implant (scleral 
and supraciliary), the trabeculo descemetic mem brane and 
the hyporeflective spaces in the bleb wall thickness and in 
suprascleral and supra-choroidal locali za tions (Figs 3A to C). 
As complications we have registered one eye with 
imme diate postoperative hypotony, which was solved in 
9 days, without sequelae. In other patient, we verified the 
anterio rization of the Esnoper-Clip® implant associated 
to trabeculo descemetic membrane rupture at 6-month 
follow-up (Figs 4A and B).
DISCuSSION
Previous studies suggested that DS with the use of 
implants have good efficacy and low rate of perioperative 
complications.1-8,14 During the first year of follow-up, we 
found a maintained postoperative IOP decrease after 
DS with Esnoper-Clip® implant, similar to the values 
published with other implants,20,22 with almost no need of 
glaucoma medications. The hypotony reported happened 
in the only patient in which mitomycin C was used, and 
so it may be correlated with its use. The anteriorization 
of the implant with trabeculodescemetic membrane 
rupture, registered at 6-month follow-up, did not show 
significant clinical repercussions or at the aqueous humor 
drainage, as noticed by the low IOP values measured. In 
contrast to other implants, such as Esnoper®, Esnoper-
Clip® is not sutured to sclera so it may predispose to 
implant dislocation, a complication that was never been 
documented in 5 years of experience of the authors with 
the first implant.
In the last few years, with new technological advances, 
filtering bleb structure has been studied [by confocal 
microscopy,24,25 ultrasound biomicroscopy (UBM)20 and 
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AS-OCT16-24] in order to better understand the drainage 
pathways and its role on glaucoma surgery success. In 
this study, AS-OCT allowed to analyze the localization 
of the implant, the trabeculodescemetic membrane and 
hyporeflective spaces suggesting liquid content and 
so its drainage pathways, as already described in the 
literature.16,17,19,20 Esnoper-Clip® implant acts as a space 
maintainer and leads to the aqueous humor drainage 
to suprachoroidal, supraescleral and intraconjunctival 
spaces, as suggested by the images captured by AS-OCT. 
Therefore, this high-resolution imaging method may 
complement the clinical evaluation during the follow-
up time.
In order to understand the relevance of this new 
implant in the clinical practice, further prospective, 
controlled, randomized and multicenter studies, with 
larger samples and longer follow-up, would be important. 
Moreover, studies should be done to compare DS with 
Esnoper-Clip® with the use of other implants and with 
trabeculectomy with or without antimetabolites. Also, 
structure-function correlation studies, using AS-OCT, 
would be of value, as is already described for other 
implants.17,19-21,23,24
CONCLuSION
Our first five DS with Esnoper-Clip® implant analysis 
suggest an effective and well-tolerated method to 
reduce IOP. AS-OCT is a noninvasive imaging technique 
that allows morphological analysis of the drainage 
mechanisms after glaucoma surgery.
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